David Barton
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Viral | 39 | 2020 | 597 | 6.830 |
Why?
| Poliovirus | 29 | 2020 | 77 | 6.100 |
Why?
| Virus Replication | 18 | 2020 | 409 | 2.640 |
Why?
| Endoribonucleases | 9 | 2014 | 73 | 2.530 |
Why?
| Viral Proteins | 11 | 2020 | 300 | 2.190 |
Why?
| Brain Injuries, Traumatic | 5 | 2023 | 325 | 1.840 |
Why?
| HeLa Cells | 27 | 2020 | 609 | 1.610 |
Why?
| Picornaviridae | 3 | 2020 | 18 | 1.600 |
Why?
| Ribavirin | 3 | 2020 | 89 | 1.390 |
Why?
| Snake Bites | 2 | 2019 | 59 | 1.240 |
Why?
| Recombination, Genetic | 3 | 2019 | 175 | 1.230 |
Why?
| Viral Nonstructural Proteins | 3 | 2020 | 60 | 0.970 |
Why?
| Hepacivirus | 6 | 2014 | 234 | 0.950 |
Why?
| Polyadenylation | 2 | 2015 | 38 | 0.940 |
Why?
| Agkistrodon | 2 | 2023 | 19 | 0.880 |
Why?
| Air Ambulances | 1 | 2023 | 47 | 0.860 |
Why?
| Emergency Medical Services | 2 | 2023 | 635 | 0.850 |
Why?
| Nucleic Acid Conformation | 10 | 2010 | 674 | 0.850 |
Why?
| RNA | 5 | 2020 | 854 | 0.810 |
Why?
| Drug Resistance, Viral | 3 | 2020 | 99 | 0.800 |
Why?
| Murine hepatitis virus | 1 | 2020 | 16 | 0.770 |
Why?
| Protein Biosynthesis | 11 | 2008 | 408 | 0.730 |
Why?
| Hypogonadism | 2 | 2020 | 77 | 0.730 |
Why?
| Antiviral Agents | 5 | 2020 | 670 | 0.730 |
Why?
| Coral Snakes | 1 | 2019 | 1 | 0.700 |
Why?
| Hydrocortisone | 1 | 2021 | 315 | 0.690 |
Why?
| Bupivacaine | 1 | 2018 | 34 | 0.660 |
Why?
| Polyribosomes | 2 | 2008 | 23 | 0.650 |
Why?
| Nerve Block | 1 | 2018 | 65 | 0.630 |
Why?
| Amino Acid Substitution | 5 | 2020 | 278 | 0.600 |
Why?
| Cognitive Dysfunction | 1 | 2021 | 309 | 0.590 |
Why?
| Viral Core Proteins | 3 | 2003 | 21 | 0.580 |
Why?
| RNA Stability | 4 | 2014 | 105 | 0.580 |
Why?
| RNA, Messenger | 6 | 2008 | 2720 | 0.570 |
Why?
| Leucine | 1 | 2016 | 117 | 0.550 |
Why?
| Base Sequence | 14 | 2012 | 2186 | 0.550 |
Why?
| RNA Cleavage | 1 | 2014 | 8 | 0.490 |
Why?
| Ribonuclease, Pancreatic | 1 | 2014 | 12 | 0.490 |
Why?
| Templates, Genetic | 3 | 2010 | 59 | 0.490 |
Why?
| Influenza A virus | 1 | 2014 | 112 | 0.480 |
Why?
| DNA-Directed RNA Polymerases | 3 | 2020 | 55 | 0.460 |
Why?
| Transcription, Genetic | 7 | 2015 | 1355 | 0.450 |
Why?
| Uridine | 2 | 2009 | 30 | 0.440 |
Why?
| Molecular Sequence Data | 11 | 2012 | 2933 | 0.440 |
Why?
| Pain | 1 | 2018 | 746 | 0.440 |
Why?
| Host-Pathogen Interactions | 1 | 2014 | 313 | 0.410 |
Why?
| Ribosomes | 2 | 2004 | 142 | 0.390 |
Why?
| Conserved Sequence | 2 | 2008 | 220 | 0.390 |
Why?
| Cysteine Endopeptidases | 2 | 2008 | 61 | 0.390 |
Why?
| Poly U | 1 | 2010 | 3 | 0.370 |
Why?
| Open Reading Frames | 2 | 2008 | 121 | 0.370 |
Why?
| Alcohol Drinking | 1 | 2016 | 668 | 0.360 |
Why?
| Poly A | 1 | 2010 | 48 | 0.360 |
Why?
| Deoxycytosine Nucleotides | 1 | 2009 | 11 | 0.360 |
Why?
| Humans | 46 | 2023 | 122796 | 0.360 |
Why?
| Enterovirus | 2 | 2012 | 72 | 0.340 |
Why?
| Mutation | 8 | 2020 | 3493 | 0.340 |
Why?
| Enterovirus C, Human | 1 | 2008 | 1 | 0.330 |
Why?
| Poly C | 1 | 2008 | 3 | 0.330 |
Why?
| Eukaryotic Initiation Factor-4G | 1 | 2008 | 5 | 0.330 |
Why?
| Wounds and Injuries | 2 | 2016 | 813 | 0.330 |
Why?
| Uridine Monophosphate | 2 | 2008 | 15 | 0.310 |
Why?
| Dinucleoside Phosphates | 1 | 2007 | 23 | 0.310 |
Why?
| Base Composition | 1 | 2007 | 77 | 0.310 |
Why?
| Mutagenesis, Site-Directed | 3 | 2016 | 368 | 0.260 |
Why?
| Ribonucleases | 1 | 2004 | 54 | 0.260 |
Why?
| Dendritic Spines | 2 | 2016 | 52 | 0.250 |
Why?
| Kinetics | 5 | 2008 | 1658 | 0.240 |
Why?
| DNA Mutational Analysis | 2 | 2016 | 390 | 0.240 |
Why?
| Ubiquitin Thiolesterase | 1 | 2023 | 38 | 0.230 |
Why?
| Observational Studies as Topic | 1 | 2023 | 91 | 0.220 |
Why?
| 5' Untranslated Regions | 4 | 2012 | 53 | 0.220 |
Why?
| Protein Binding | 4 | 2020 | 2010 | 0.210 |
Why?
| Uridine Triphosphate | 1 | 2001 | 11 | 0.210 |
Why?
| Cell-Free System | 5 | 2008 | 53 | 0.210 |
Why?
| Hepatitis C | 1 | 2004 | 226 | 0.210 |
Why?
| Patient Acuity | 1 | 2021 | 37 | 0.210 |
Why?
| Animals | 12 | 2023 | 34133 | 0.210 |
Why?
| Protein Conformation | 3 | 2015 | 851 | 0.200 |
Why?
| Male | 12 | 2023 | 59639 | 0.200 |
Why?
| Anaphylaxis | 1 | 2023 | 144 | 0.190 |
Why?
| Genome, Viral | 4 | 2012 | 125 | 0.190 |
Why?
| Models, Molecular | 4 | 2015 | 1443 | 0.190 |
Why?
| Nucleotide Motifs | 1 | 2020 | 33 | 0.190 |
Why?
| RNA, Ribosomal | 2 | 2014 | 159 | 0.190 |
Why?
| Adult | 8 | 2021 | 32385 | 0.190 |
Why?
| Enterovirus B, Human | 1 | 2020 | 24 | 0.190 |
Why?
| Picornaviridae Infections | 1 | 2020 | 29 | 0.190 |
Why?
| Sindbis Virus | 2 | 1991 | 9 | 0.190 |
Why?
| Prospective Studies | 3 | 2023 | 6704 | 0.180 |
Why?
| Carrier Proteins | 2 | 2009 | 740 | 0.180 |
Why?
| Young Adult | 4 | 2021 | 11094 | 0.180 |
Why?
| Brain Injuries | 2 | 2016 | 488 | 0.180 |
Why?
| Ribonuclease T1 | 2 | 2009 | 5 | 0.180 |
Why?
| Pituitary Gland | 1 | 2020 | 164 | 0.170 |
Why?
| Hypothalamus | 1 | 2020 | 155 | 0.170 |
Why?
| Mutation, Missense | 2 | 2019 | 302 | 0.170 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 2009 | 84 | 0.170 |
Why?
| Fascia | 1 | 2018 | 18 | 0.170 |
Why?
| Femoral Nerve | 1 | 2018 | 17 | 0.170 |
Why?
| Guanidine | 3 | 2009 | 18 | 0.160 |
Why?
| Mice | 7 | 2020 | 15888 | 0.160 |
Why?
| Mice, Inbred C57BL | 5 | 2020 | 5020 | 0.160 |
Why?
| Apolipoprotein E4 | 1 | 2018 | 37 | 0.160 |
Why?
| Injections | 1 | 2018 | 171 | 0.160 |
Why?
| Anesthetics, Local | 1 | 2018 | 86 | 0.160 |
Why?
| Blood-Brain Barrier | 1 | 2018 | 107 | 0.150 |
Why?
| Amino Acid Sequence | 4 | 2008 | 2123 | 0.150 |
Why?
| Inflammation Mediators | 1 | 2020 | 515 | 0.150 |
Why?
| Plasmids | 3 | 2008 | 358 | 0.150 |
Why?
| Peptide Initiation Factors | 1 | 1996 | 17 | 0.140 |
Why?
| Nucleotides | 2 | 2008 | 114 | 0.140 |
Why?
| Alcohols | 1 | 2016 | 32 | 0.140 |
Why?
| Pain Management | 1 | 2018 | 306 | 0.130 |
Why?
| Microbial Sensitivity Tests | 1 | 2016 | 312 | 0.130 |
Why?
| Cross-Sectional Studies | 2 | 2016 | 4734 | 0.130 |
Why?
| Cell Line | 4 | 2014 | 2785 | 0.130 |
Why?
| Cohort Studies | 2 | 2023 | 5294 | 0.130 |
Why?
| Hydrolysis | 1 | 2014 | 189 | 0.130 |
Why?
| RNA Precursors | 1 | 1995 | 142 | 0.120 |
Why?
| Injury Severity Score | 2 | 2016 | 541 | 0.120 |
Why?
| RNA, Small Nuclear | 1 | 2014 | 33 | 0.120 |
Why?
| White Matter | 1 | 2016 | 119 | 0.120 |
Why?
| Genetic Complementation Test | 3 | 2004 | 62 | 0.120 |
Why?
| Gene Knockdown Techniques | 1 | 2014 | 322 | 0.120 |
Why?
| Sulfur Radioisotopes | 2 | 2008 | 17 | 0.120 |
Why?
| Middle Aged | 5 | 2023 | 28563 | 0.120 |
Why?
| Macrophages | 1 | 2020 | 1334 | 0.120 |
Why?
| RNA, Double-Stranded | 2 | 2004 | 52 | 0.110 |
Why?
| Binding Sites | 2 | 2008 | 1247 | 0.110 |
Why?
| Testosterone | 1 | 2016 | 353 | 0.110 |
Why?
| Adolescent | 5 | 2021 | 18948 | 0.110 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 832 | 0.110 |
Why?
| Biomarkers | 1 | 2023 | 3662 | 0.110 |
Why?
| Cells, Cultured | 1 | 2020 | 4162 | 0.110 |
Why?
| Autoantibodies | 1 | 2020 | 1353 | 0.110 |
Why?
| Follow-Up Studies | 1 | 2021 | 4768 | 0.110 |
Why?
| Models, Genetic | 2 | 2008 | 599 | 0.110 |
Why?
| Argonaute Proteins | 1 | 2012 | 30 | 0.110 |
Why?
| Patient Care Management | 1 | 2012 | 58 | 0.110 |
Why?
| Emergency Medical Technicians | 1 | 2012 | 44 | 0.100 |
Why?
| Immune Evasion | 1 | 2012 | 48 | 0.100 |
Why?
| West Nile virus | 1 | 2012 | 40 | 0.100 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 459 | 0.100 |
Why?
| West Nile Fever | 1 | 2012 | 52 | 0.100 |
Why?
| Semliki forest virus | 1 | 1991 | 3 | 0.100 |
Why?
| Neuropsychological Tests | 1 | 2016 | 1072 | 0.100 |
Why?
| Alphavirus | 1 | 1991 | 17 | 0.100 |
Why?
| Amyloid beta-Peptides | 1 | 2013 | 202 | 0.100 |
Why?
| Genes, Viral | 1 | 1991 | 94 | 0.100 |
Why?
| Interferon Type I | 1 | 2012 | 134 | 0.100 |
Why?
| Temperature | 3 | 2004 | 631 | 0.100 |
Why?
| Physical Examination | 1 | 2012 | 253 | 0.100 |
Why?
| RNA, Untranslated | 1 | 2012 | 116 | 0.090 |
Why?
| Logistic Models | 1 | 2016 | 1995 | 0.090 |
Why?
| Cerebral Cortex | 1 | 2013 | 430 | 0.090 |
Why?
| DNA Primers | 2 | 2004 | 540 | 0.090 |
Why?
| Female | 4 | 2023 | 63629 | 0.090 |
Why?
| Exoribonucleases | 1 | 2010 | 40 | 0.090 |
Why?
| Codon | 2 | 2007 | 90 | 0.090 |
Why?
| Mutagenesis | 2 | 2008 | 185 | 0.090 |
Why?
| Uracil | 1 | 2008 | 35 | 0.080 |
Why?
| Genes, Dominant | 1 | 2008 | 97 | 0.080 |
Why?
| Base Pairing | 1 | 2008 | 60 | 0.080 |
Why?
| Cytosine | 1 | 2008 | 46 | 0.080 |
Why?
| Epithelial Cells | 1 | 2014 | 995 | 0.080 |
Why?
| Cognition | 1 | 2016 | 1066 | 0.080 |
Why?
| Adenine Nucleotides | 1 | 2008 | 20 | 0.080 |
Why?
| Oligoribonucleotides | 1 | 2008 | 52 | 0.080 |
Why?
| Puromycin | 2 | 1999 | 11 | 0.080 |
Why?
| Prognosis | 1 | 2016 | 3563 | 0.080 |
Why?
| Binding, Competitive | 1 | 2008 | 205 | 0.080 |
Why?
| 3' Untranslated Regions | 1 | 2008 | 147 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 2 | 2004 | 1981 | 0.080 |
Why?
| Depression | 1 | 2016 | 1190 | 0.080 |
Why?
| Protein Processing, Post-Translational | 2 | 2008 | 421 | 0.080 |
Why?
| DNA, Complementary | 1 | 2008 | 270 | 0.080 |
Why?
| RNA Caps | 2 | 2012 | 35 | 0.080 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 188 | 0.070 |
Why?
| Aged | 4 | 2021 | 20495 | 0.070 |
Why?
| Selection, Genetic | 1 | 2007 | 254 | 0.070 |
Why?
| Electronic Health Records | 1 | 2012 | 842 | 0.070 |
Why?
| Gene Expression Regulation, Viral | 1 | 2005 | 86 | 0.070 |
Why?
| Quality of Life | 1 | 2016 | 2457 | 0.070 |
Why?
| Sequence Deletion | 2 | 2004 | 175 | 0.060 |
Why?
| MicroRNAs | 1 | 2012 | 661 | 0.060 |
Why?
| Phylogeny | 1 | 2008 | 830 | 0.060 |
Why?
| Cytoplasm | 1 | 2004 | 276 | 0.060 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2023 | 74 | 0.060 |
Why?
| Horses | 1 | 2023 | 109 | 0.060 |
Why?
| Antivenins | 1 | 2023 | 59 | 0.060 |
Why?
| Retrospective Studies | 4 | 2016 | 13433 | 0.050 |
Why?
| Craniocerebral Trauma | 2 | 2016 | 154 | 0.050 |
Why?
| Capsid | 1 | 2002 | 77 | 0.050 |
Why?
| Patients | 1 | 2023 | 176 | 0.050 |
Why?
| Risk Factors | 1 | 2016 | 9381 | 0.050 |
Why?
| Interferons | 1 | 2002 | 154 | 0.050 |
Why?
| Medical Audit | 2 | 1991 | 78 | 0.050 |
Why?
| Models, Biological | 1 | 2008 | 1756 | 0.050 |
Why?
| Time Factors | 2 | 2004 | 6682 | 0.050 |
Why?
| Anisomycin | 1 | 1999 | 5 | 0.050 |
Why?
| Ricin | 1 | 1999 | 8 | 0.050 |
Why?
| Cycloheximide | 1 | 1999 | 59 | 0.050 |
Why?
| Peptide Chain Elongation, Translational | 1 | 1999 | 18 | 0.050 |
Why?
| Enzyme Activation | 1 | 2002 | 864 | 0.050 |
Why?
| Protein Synthesis Inhibitors | 1 | 1999 | 48 | 0.050 |
Why?
| Diphtheria Toxin | 1 | 1999 | 63 | 0.040 |
Why?
| Protein Domains | 1 | 2020 | 219 | 0.040 |
Why?
| Apolipoprotein E3 | 1 | 2018 | 4 | 0.040 |
Why?
| Evolution, Molecular | 1 | 2002 | 459 | 0.040 |
Why?
| Capillary Permeability | 1 | 2018 | 148 | 0.040 |
Why?
| Inflammation | 2 | 2020 | 2598 | 0.040 |
Why?
| Electrophoresis, Agar Gel | 1 | 1996 | 25 | 0.040 |
Why?
| Unconsciousness | 1 | 2016 | 26 | 0.040 |
Why?
| Fluoresceins | 1 | 2016 | 47 | 0.030 |
Why?
| Maze Learning | 1 | 2016 | 87 | 0.030 |
Why?
| Chromatography, Affinity | 1 | 1996 | 87 | 0.030 |
Why?
| Subcellular Fractions | 1 | 1996 | 86 | 0.030 |
Why?
| Indicators and Reagents | 1 | 1996 | 102 | 0.030 |
Why?
| Cytidine Triphosphate | 1 | 1995 | 15 | 0.030 |
Why?
| Guanidines | 1 | 1995 | 38 | 0.030 |
Why?
| Golgi Apparatus | 1 | 2016 | 93 | 0.030 |
Why?
| tau Proteins | 1 | 2016 | 80 | 0.030 |
Why?
| Point Mutation | 1 | 1996 | 231 | 0.030 |
Why?
| Amyloid | 1 | 2016 | 89 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 336 | 0.030 |
Why?
| Methionine | 1 | 1995 | 147 | 0.030 |
Why?
| Immunoblotting | 1 | 1995 | 318 | 0.030 |
Why?
| Structure-Activity Relationship | 1 | 1996 | 536 | 0.030 |
Why?
| Cloning, Molecular | 1 | 1996 | 551 | 0.030 |
Why?
| Peptides | 1 | 1999 | 893 | 0.030 |
Why?
| Autoimmunity | 1 | 2020 | 852 | 0.030 |
Why?
| Hospitals, Teaching | 2 | 1991 | 114 | 0.030 |
Why?
| Dentate Gyrus | 1 | 2013 | 32 | 0.030 |
Why?
| Coloring Agents | 1 | 2013 | 75 | 0.030 |
Why?
| Alanine | 1 | 2013 | 103 | 0.030 |
Why?
| Azepines | 1 | 2013 | 74 | 0.030 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2013 | 75 | 0.030 |
Why?
| Poliomyelitis | 1 | 1993 | 27 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2020 | 2599 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 998 | 0.030 |
Why?
| Functional Laterality | 1 | 2013 | 215 | 0.030 |
Why?
| District of Columbia | 1 | 2012 | 28 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2018 | 2079 | 0.030 |
Why?
| Behavior, Animal | 1 | 2016 | 486 | 0.030 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2012 | 20 | 0.030 |
Why?
| Ambulances | 1 | 2012 | 51 | 0.030 |
Why?
| Recombinant Proteins | 1 | 1996 | 1318 | 0.030 |
Why?
| Rhinovirus | 1 | 2012 | 40 | 0.030 |
Why?
| Escherichia coli | 1 | 1996 | 767 | 0.030 |
Why?
| Octoxynol | 1 | 1991 | 12 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1991 | 42 | 0.030 |
Why?
| Methylation | 1 | 2012 | 209 | 0.030 |
Why?
| Deoxycholic Acid | 1 | 1991 | 21 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 839 | 0.020 |
Why?
| Detergents | 1 | 1991 | 46 | 0.020 |
Why?
| Virulence | 1 | 2012 | 254 | 0.020 |
Why?
| DEAD Box Protein 58 | 1 | 2010 | 9 | 0.020 |
Why?
| Solubility | 1 | 1991 | 240 | 0.020 |
Why?
| DEAD-box RNA Helicases | 1 | 2010 | 59 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2013 | 836 | 0.020 |
Why?
| Substrate Specificity | 1 | 2010 | 375 | 0.020 |
Why?
| Receptors, Immunologic | 1 | 2010 | 228 | 0.020 |
Why?
| Brain Concussion | 1 | 2016 | 470 | 0.020 |
Why?
| Hippocampus | 1 | 2013 | 747 | 0.020 |
Why?
| Chick Embryo | 1 | 1988 | 131 | 0.020 |
Why?
| Receptors, Cell Surface | 1 | 2010 | 368 | 0.020 |
Why?
| Hospital Mortality | 1 | 1991 | 901 | 0.020 |
Why?
| Nerve Tissue Proteins | 1 | 2010 | 557 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 1991 | 560 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2016 | 3799 | 0.020 |
Why?
| Mice, Knockout | 1 | 2012 | 2737 | 0.020 |
Why?
| Immunity, Innate | 1 | 2010 | 762 | 0.020 |
Why?
| Membrane Proteins | 1 | 2010 | 1093 | 0.020 |
Why?
| Fibroblasts | 1 | 1988 | 846 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2010 | 2904 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2002 | 207 | 0.010 |
Why?
| Surface Properties | 1 | 2002 | 402 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 1991 | 1922 | 0.010 |
Why?
| Brefeldin A | 1 | 1997 | 15 | 0.010 |
Why?
| Oximes | 1 | 1997 | 18 | 0.010 |
Why?
| Cyclopentanes | 1 | 1997 | 16 | 0.010 |
Why?
| Genetic Techniques | 1 | 1997 | 61 | 0.010 |
Why?
| Benzimidazoles | 1 | 1997 | 142 | 0.010 |
Why?
| Sulfonamides | 1 | 1997 | 455 | 0.010 |
Why?
| Reading Frames | 1 | 1992 | 1 | 0.010 |
Why?
| Helper Viruses | 1 | 1992 | 2 | 0.010 |
Why?
| Virion | 1 | 1992 | 78 | 0.010 |
Why?
| England | 1 | 1991 | 72 | 0.010 |
Why?
| Peer Review | 1 | 1991 | 43 | 0.010 |
Why?
| Trauma Severity Indices | 1 | 1991 | 128 | 0.010 |
Why?
| Transfection | 1 | 1992 | 909 | 0.010 |
Why?
| United Kingdom | 1 | 1991 | 260 | 0.010 |
Why?
| Aged, 80 and over | 2 | 1991 | 6845 | 0.010 |
Why?
| Central Nervous System | 1 | 1991 | 244 | 0.010 |
Why?
| Infant | 2 | 1991 | 8523 | 0.000 |
Why?
| Child, Preschool | 2 | 1991 | 9755 | 0.000 |
Why?
| Survival Rate | 1 | 1991 | 1810 | 0.000 |
Why?
| Child | 2 | 1991 | 19561 | 0.000 |
Why?
|
|
Barton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|